Season's Savings | ₹5/mo for 3 months

₹199/month after first 3 months. Renews automatically. Terms apply.
Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere cover art

Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere

Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere

Written by: Julio G. Martinez-Clark
Listen for free

About this listen

Hosted by bioaccess® CEO, Julio G. Martinez-Clark, the Global Trial Accelerators™ podcast delivers actionable insights for Medtech, Biopharma, and Radiopharma innovators battling lengthy timelines and costly delays. Each episode features candid conversations with clinical trial pioneers, regulatory strategists, and startup founders who’ve slashed 6–12 months off approvals by leveraging emerging regions like Latin America, Eastern Europe, and Australia.


What You’ll Learn:

  • Speed Secrets: How to secure ethics approval in 4–6 weeks (vs. 6+ months in US/EU) using harmonized pathways like MINSA (Panama), ALIMS (Serbia), and Australia’s CTN.
  • Cost-to-Speed Hacks: Operational strategies to reduce trial budgets by 30% while maintaining FDA/EMA compliance.
  • Global Patient Access: Leverage treatment-naive populations in cardiology, rare diseases, and advanced therapies across 50+ pre-vetted sites.


Why Listen?

  • Actionable Playbooks: Reverse-engineer success stories from startups that enrolled cohorts 50% faster and secured Series B funding 12–18 months early.
  • Regulatory Intel: Stay ahead of shifting LATAM, Balkans, and APAC guidelines with on-the-ground experts.
  • Future-Proof Insights: Explore decentralized trials, AI-driven recruitment, and post-trial commercialization in $1B+ markets.

“bioaccess®’s Serbia site activated in 8 weeks-9 months faster than our EU delay.


This podcast is why we partnered with them.”
– Digital Health Startup CEO


New episodes drop weekly. Subscribe to unlock your shortcut to global trial velocity.


Brought to you by bioaccess® – Turning “anywhere” into accelerated FDA/EMA submissions since 2010.

© 2026 Global Trial Accelerators™: Fast-Tracking First-in-Human Trials, Anywhere
Economics Hygiene & Healthy Living Leadership Management & Leadership Physical Illness & Disease
Episodes
  • Michael Drues, President at Vascular Sciences
    Nov 13 2026

    In this episode, we welcome Dr. Michael Drues, President of Vascular Sciences, a consulting, education, and training company specializing in medical devices, pharmaceuticals, and biotechnology.

    Dr. Drues holds a Ph.D. in Biomedical Engineering from Iowa State University and has extensive experience supporting organizations ranging from startups to Fortune 100 companies. His expertise includes medical device development, FDA regulatory strategy, clinical trial design, combination products, and healthcare technology commercialization.

    Throughout his career, he has collaborated with leading regulatory agencies and organizations, including the FDA, Health Canada, the U.S. and European Patent Offices, and CMS. He is also an internationally recognized speaker and Adjunct Professor, teaching graduate-level courses in regulatory affairs, biomedical engineering, biotechnology, and medical technology.

    Join us as we highlight Dr. Drues' expertise in medical innovation, regulatory science, and the challenges of bringing new healthcare technologies to market.

    Show More Show Less
    1 hr and 7 mins
  • Varun Kalaiarasan, PhD Researcher at University of Cincinnati
    Nov 6 2026

    In this episode, we sit down with Varun Kalaiarasan, a PhD researcher in Biomedical Engineering at the University of Cincinnati, whose interdisciplinary background combines mechanical engineering, applied machine learning, and venture capital.

    Varun shares his involvement in advancing VortexPAP, an innovative medical device being developed to improve comfort and treatment adherence for individuals living with obstructive sleep apnea. Working alongside Dr. Liran Oren, Varun focuses on the venture and commercialization side, helping navigate the path toward regulatory approval and market entry.

    Discover how biomedical research, entrepreneurship, and patient-centered innovation come together to address real-world healthcare challenges and shape the future of medical technology.

    Show More Show Less
    42 mins
  • Ryan Beal, Chief Executive Officer at Dyve Biosciences
    Oct 23 2026

    In this episode, we welcome Dr. Ryan Beal, Founder and CEO of Dyve Biosciences, to discuss an innovative transdermal drug delivery approach targeting tumor acidity to help the immune system better recognize and attack cancer cells.

    A physician and serial entrepreneur, Ryan brings extensive experience in pharmaceutical innovation, clinical development, and healthcare entrepreneurship. Join us to explore the science behind Dyve Biosciences and the future of cancer treatment.

    Show More Show Less
    41 mins
adbl_web_anon_alc_button_suppression_t1
No reviews yet